(Q41127253)

27 September 2017

1 reference

title

Inhaled antibiotics in cystic fibrosis: a review (English)

1 reference

27 September 2017

0 references

0 references

C Toso

1

1 reference

27 September 2017

D M Williams

series ordinal

2

1 reference

27 September 2017

P G Noone

series ordinal

3

1 reference

27 September 2017

language of work or name

English

0 references

publication date

1 July 1996

1 reference

Annals of Pharmacotherapy

27 September 2017

published in

1 reference

27 September 2017

volume

30

1 reference

27 September 2017

issue

7-8

1 reference

27 September 2017

page(s)

840-850

1 reference

Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA

27 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F106002809603000723

Identification of the cystic fibrosis gene: genetic analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809603000723

Identification of the cystic fibrosis gene: chromosome walking and jumping

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809603000723

The spectrum of cystic fibrosis mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809603000723

Lung disease in cystic fibrosis--an updated concept

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809603000723

Pseudomonas aeruginosa: biology, mechanisms of virulence, epidemiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809603000723

Inhaled antibiotics in cystic fibrosis: is there a therapeutic effect?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809603000723

A placebo-controlled trial of cephalexin therapy in the ambulatory management of patients with cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809603000723

Aerosol deposition considerations in inhalation therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809603000723

Calculated deposition of inhaled particles in the airway generations of normal subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809603000723

Effect of lung function and mode of inhalation on penetration of aerosol into the human lung

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809603000723

Aerosol antibiotic treatment in cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809603000723

Quantitative deposition of aerosolized gentamicin in cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809603000723

Pulmonary deposition of aerosols in children with cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809603000723

Local treatment of respiratory infections with antibiotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809603000723

Evaluation of jet nebulisers for use with gentamicin solution

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809603000723

Deposition of carbenicillin aerosols in cystic fibrosis: effects of nebuliser system and breathing pattern

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809603000723

Evaluation of two commercial jet nebulisers and three compressors for the nebulisation of antibiotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809603000723

Use of Gentamicin in Children with Cystic Fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809603000723

Tobramycin treatment of pseudomonas aeruginosa infections in cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809603000723

Antibiotic therapy in cystic fibrosis: evaluation of clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809603000723

Aerosol delivery of antibiotics to the lower airways of patients with cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809603000723

Efficacy of inhaled amikacin as adjunct to intravenous combination therapy (ceftazidime and amikacin) in cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809603000723

Aerosol carbenicillin and gentamicin treatment of Pseudomonas aeruginosa infection in patients with cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809603000723

Long-term effects of inhaled tobramycin in patients with cystic fibrosis colonized with Pseudomonas aeruginosa.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809603000723

Efficacy of aerosolized tobramycin in patients with cystic fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809603000723

Inhaled antibiotics in cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809603000723

Prevention of chronic Pseudomonas aeruginosa colonisation in cystic fibrosis by early treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809603000723

Antibiotic prophylaxis in cystic fibrosis: inhaled cephaloridine as an adjunct to oral cloxacillin

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809603000723

Variability of airways hyper-reactivity and allergy in cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809603000723

10.1177/106002809603000723

21 January 2018

Identifiers

DOI

1 reference

release_22wa3kqttzd65bt5kinqh6p6ky

27 September 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/22wa3kqttzd65bt5kinqh6p6ky

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference